Active, not recruitingPhase 2NCT01220583
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
Studying Squamous cell carcinoma of head and neck
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radiation Therapy Oncology Group
- Principal Investigator
- Cristina P. Rodriguez, MDOHSU Knight Cancer Institute
- Intervention
- cisplatin(drug)
- Enrollment
- 252 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2011 – 2028
Study locations (30)
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- The Kirklin Clinic at Acton Road, Birmingham, Alabama, United States
- Arizona Breast Cancer Specialists-Gilbert, Gilbert, Arizona, United States
- Arizona Center for Cancer Care-Peoria, Peoria, Arizona, United States
- Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
- Arizona Breast Cancer Specialists-Phoenix, Phoenix, Arizona, United States
- Arizona Oncology-Deer Valley Center, Phoenix, Arizona, United States
- Arizona Breast Cancer Specialists, Scottsdale, Arizona, United States
- Arizona Breast Cancer Specialists-Scottsdale, Scottsdale, Arizona, United States
- Arizona Oncology Services Foundation, Scottsdale, Arizona, United States
- Arizona Center for Cancer Care-Surprise, Surprise, Arizona, United States
- University of Arizona Cancer Center-Orange Grove Campus, Tucson, Arizona, United States
- Banner University Medical Center - Tucson, Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI) · NRG Oncology
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01220583 on ClinicalTrials.govOther trials for Squamous cell carcinoma of head and neck
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07333274Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell CarcinomaShandong Cancer Hospital and Institute
- RECRUITINGPHASE1NCT07182149A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsNormunity AccelCo, Inc.
- RECRUITINGPHASE3NCT07026474Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCCUniversität des Saarlandes
- RECRUITINGNANCT07203911Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled TrialTobias Todsen
- RECRUITINGNANCT07180901Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck CancerCentre hospitalier de l'Université de Montréal (CHUM)
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT07435415Local Injection Methylene Blue Combined With Radiation in HNSCC PatientsChina Medical University Hospital
- RECRUITINGPHASE2NCT07088211Sacituzumab Tirumotecan and Toripalimab in the First-line Treatment of HNSCCShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- RECRUITINGPHASE2NCT07040956A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.West China Hospital
See all trials for Squamous cell carcinoma of head and neck →